APOTHEEK JUST PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK JUST PHARMA
Largest movements
- Receivables within one year -€83,820
down €83,820 (-17.7%), from €472,730 to €388,910
of which Other amounts receivable: -€102,766
- Stocks and contracts +€16,830
up €16,830 (+10.8%), from €155,196 to €172,026
- Cash +€11,874
up €11,874 (+11.7%), from €101,457 to €113,331
mainly Net result for the year (+€184,221) and Receivables within one year (+€83,820)
- Trade debts -€119,896
down €119,896 (-65.0%), from €184,592 to €64,696
- Profit (loss) carried forward +€54,221
up €54,221 (+24.8%), from €218,930 to €273,150
- Other debts +€45,000
up €45,000 (+52.9%), from €85,000 to €130,000
- Debts after one year -€25,851
down €25,851 (-78.9%), from €32,774 to €6,922
- Gross operating margin +€31,807
up €31,807 (+12.9%), from €247,081 to €278,888
- Staff costs -€10,574
down €10,574 (-14.2%), from €74,263 to €63,690
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €816,092 | €765,008 | -€51,084 | -6.3% |
| Fixed assets | 21/28 | €80,678 | €85,728 | +€5,049 | +6.3% |
| Tangible fixed assets | 22/27 | €80,475 | €85,524 | +€5,049 | +6.3% |
| Land and buildings | 22 | €64,737 | €62,324 | -€2,413 | -3.7% |
| Furniture and vehicles | 24 | €15,738 | €23,200 | +€7,462 | +47.4% |
| Financial fixed assets | 28 | €204 | €204 | = | 0.0% |
| Current assets | 29/58 | €735,414 | €679,280 | -€56,134 | -7.6% |
| Stocks and contracts in progress | 3 | €155,196 | €172,026 | +€16,830 | +10.8% |
| Stocks | 30/36 | €155,196 | €172,026 | +€16,830 | +10.8% |
| Amounts receivable within one year | 40/41 | €472,730 | €388,910 | -€83,820 | -17.7% |
| Trade receivables | 40 | €93,517 | €112,463 | +€18,946 | +20.3% |
| Other amounts receivable | 41 | €379,213 | €276,447 | -€102,766 | -27.1% |
| Cash at bank and in hand | 54/58 | €101,457 | €113,331 | +€11,874 | +11.7% |
| Deferred charges and accrued income | 490/1 | €6,031 | €5,013 | -€1,019 | -16.9% |
| Total equity and liabilities | 10/49 | €816,092 | €765,008 | -€51,084 | -6.3% |
| Equity | 10/15 | €473,507 | €527,728 | +€54,221 | +11.5% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Contributions outside capital | 11 | €61,500 | €61,500 | = | 0.0% |
| Other | 1109/19 | €61,500 | €61,500 | = | 0.0% |
| Reserves | 13 | €193,077 | €193,077 | = | 0.0% |
| Tax-exempt reserves | 132 | €708 | €708 | = | 0.0% |
| Distributable reserves | 133 | €192,369 | €192,369 | = | 0.0% |
| Profit (loss) carried forward | 14 | €218,930 | €273,150 | +€54,221 | +24.8% |
| Amounts payable | 17/49 | €342,585 | €237,280 | -€105,305 | -30.7% |
| Amounts payable after more than one year | 17 | €32,774 | €6,922 | -€25,851 | -78.9% |
| Financial debts | 170/4 | €32,774 | €6,922 | -€25,851 | -78.9% |
| Amounts payable within one year | 42/48 | €308,707 | €230,358 | -€78,350 | -25.4% |
| Current portion of amounts payable after more than one year | 42 | €27,733 | €25,851 | -€1,882 | -6.8% |
| Trade debts | 44 | €184,592 | €64,696 | -€119,896 | -65.0% |
| Suppliers | 440/4 | €184,592 | €64,696 | -€119,896 | -65.0% |
| Taxes, remuneration and social security | 45 | €11,382 | €9,811 | -€1,571 | -13.8% |
| Taxes | 450/3 | €632 | €21 | -€611 | -96.7% |
| Remuneration and social security | 454/9 | €10,750 | €9,790 | -€960 | -8.9% |
| Other amounts payable | 47/48 | €85,000 | €130,000 | +€45,000 | +52.9% |
| Accrued charges and deferred income | 492/3 | €1,104 | - | -€1,104 | |
| Remuneration, social security and pensions | 62 | €74,263 | €63,690 | -€10,574 | -14.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,943 | €8,175 | +€2,232 | +37.6% |
| Other operating charges | 640/8 | €3,906 | €4,100 | +€195 | +5.0% |
| Gross operating margin | 9900 | €247,081 | €278,888 | +€31,807 | +12.9% |
| Operating profit (loss) | 9901 | €162,969 | €202,923 | +€39,955 | +24.5% |
| Financial income | 75/76B | €752 | €680 | -€72 | -9.5% |
| Recurring financial income | 75 | €752 | €680 | -€72 | -9.5% |
| Financial charges | 65/66B | €2,951 | €1,337 | -€1,614 | -54.7% |
| Recurring financial charges | 65 | €2,951 | €1,337 | -€1,614 | -54.7% |
| Profit (loss) for the period before taxes | 9903 | €160,769 | €202,266 | +€41,497 | +25.8% |
| Income taxes | 67/77 | €19,086 | €18,045 | -€1,041 | -5.5% |
| Profit (loss) for the period | 9904 | €141,683 | €184,221 | +€42,538 | +30.0% |
| Profit (loss) for the period to be appropriated | 9905 | €141,683 | €184,221 | +€42,538 | +30.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.